Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Comment by Dibah42on Feb 18, 2016 1:56pm
213 Views
Post# 24571630

RE:class action

RE:class action
oceanblvd wrote: One valid way to get additional funds from the company is a class action suite that i am looking into. 
Prior to this vote it was never revealed by the company directors or accountants that CUR with only one million in the bank would have been virtually wiped out by the unrecorded liability for severance pay under Canadian law.  Certainly the option acceleration is morally wrong if not leally so. The board would not be acting under its fiduciary responcibility if it approves such action . 

If anyone has any thoughts on this including Todd Axelrod please make yourselves heard.



Todd A, after his massive purchases at $.09 and $0.11  in Jan '15,  is likely one of the few who is in the green.  I wouldn't hold my breath.

<< Previous
Bullboard Posts
Next >>